Frost Radar™: Antibody-Drug Conjugate Contract Development and Manufacturing Organizations, 2025
Description
This Frost Radar™ analyzes the competitive landscape of the antibody-drug conjugate (ADC) contract development and manufacturing organization (CDMO) market. Companies provide the foundational manufacturing and development services for what has become one of the most dynamic and valuable therapeutic modalities in oncology. The success of the ADC revolution, which is transforming cancer treatment, is directly dependent on the capabilities of the specialized CDMOs profiled in this analysis. Understanding the strategies, strengths, and weaknesses of these players is essential for any stakeholder in the biopharmaceutical industry.
To succeed in this demanding environment, a CDMO must provide a comprehensive, end-to-end service offering. This includes capabilities in monoclonal antibody production, high-potency active pharmaceutical ingredient synthesis, advanced bioconjugation, and sterile fill-finish drug product manufacturing. These services must be supported by state-of-the-art facilities that require massive capital investment and an equally deep investment in the scientific and technical talent needed to manage these complex processes.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
To succeed in this demanding environment, a CDMO must provide a comprehensive, end-to-end service offering. This includes capabilities in monoclonal antibody production, high-potency active pharmaceutical ingredient synthesis, advanced bioconjugation, and sterile fill-finish drug product manufacturing. These services must be supported by state-of-the-art facilities that require massive capital investment and an equally deep investment in the scientific and technical talent needed to manage these complex processes.
Frost & Sullivan analyzes numerous companies in an industry. Those selected for further analysis based on their leadership or other distinctions are benchmarked across 10 Growth and Innovation criteria to reveal their position on the Frost Radar™. The publication presents competitive profiles of each company on the Frost Radar™ considering their strengths and the opportunities that best fit those strengths.
Table of Contents
81 Pages
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
